BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2014
View Archived Issues
A functional serotonin receptor polymorphism as a biomarker for cardiovascular disease
Read More
GlycoMimetics presents data from phase II trial of GMI-1070 in sickle cell disease
Read More
Stress-related transcription factor promotes fibrosis and oncogenesis
Read More
Application of site-directed RNA editing to correct disease-causing genetic mutations
Read More
Development of a novel ROR1 peptide-based cancer vaccine
Read More
Astellas Pharma and ClearPath Development to build vaccine company portfolio
Read More
Emmaus Medical completes all patient visits in phase III sickle cell disease trial
Read More
Trovagene and US Oncology Research collaborate on urine-based KRAS testing study
Read More
ERYtech plans phase II study of ERY-ASP in pancreatic cancer
Read More
DURECT grants Impax worldwide rights to develop and commercialize ELADUR pain patch
Read More
Amunix and Janssen extend worldwide collaboration and licensing agreement
Read More
Galena enrolls first patient in phase II trial of GALE-301 cancer immunotherapy in ovarian cancer
Read More
Immunovative Therapies updates Allovax plans
Read More
Takeda's vedolizumab enters phase III trials in Japan for ulcerative colitis and Crohn's disease
Read More
Adocia initiates phase IIa trial of ultra-fast acting formulation of insulin lispro
Read More
FDA accepts NPS Pharmaceuticals' BLA for Natpara for hypoparathyroidism
Read More
Reata reports discovery of epoxidized triterpenoids
Read More
Austrian group patents novel agents for protozoal infections
Read More
Ribomic presents new aptamers for rheumatoid arthritis and other disorders
Read More
Novel LPA-1 receptor antagonists presented by Roche
Read More
Roche divulges novel FABP inhibitors
Read More
FDA approves phase IIb study of PRO-140 for HIV-1
Read More
TeaRx begins phase II trial of novel anticoagulant in Russia
Read More
Catalyst Pharmaceutical reports cardiac safety results from phase III Firdapse trial
Read More
Forest Laboratories enters definitive agreement to acquire Aptalis
Read More
Bristol-Myers Squibb and AstraZeneca gain FDA approval for Forxiga in type 2 diabetes
Read More
Daiichi Sankyo files applications for oral, once-daily anticoagulant edoxaban in Europe and U.S.
Read More
GSK obtains accelerated FDA approval for use of Mekinist in combination with Tafinlar
Read More